Glemevose 1mg/500mg/0.2mg Tablet
Marketer
Beloorbayir Biotech Limited
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Glemevose 1mg/500mg/0.2mg Tablet
Diabeva 1mg/500mg/0.2mg tablets are classified as antidiabetic medications. This combination drug treats type 2 diabetes in adults by regulating blood glucose. Diabeva 1mg/500mg/0.2mg tablets should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is vital, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. Remember, it's a component of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. The most prevalent adverse effect is hypoglycemia (low blood sugar). Learn to identify symptoms like sweating, dizziness, headache, and tremors, and know how to manage them. Maintain regular mealtimes and carry a fast-acting glucose source, such as sugary snacks or juice. Alcohol consumption increases hypoglycemia risk and should be avoided. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Inform your doctor of any history of heart disease before commencing treatment; it may not be appropriate. Pregnant or breastfeeding individuals should consult their physician prior to use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to assess blood cell counts and liver function.
Uses of Glemevose 1mg/500mg/0.2mg Tablet
Managing type 2 diabetes
Major Benefits of Glemevose 1mg/500mg/0.2mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the Glemevose 1mg/500mg/0.2mg Tablet whole; avoid chewing, crushing, or fracturing it. Consumption should occur on an empty stomach.
Common Side effects of Glemevose 1mg/500mg/0.2mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glemevose 1mg/500mg/0.2mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glemevose 1mg/500mg/0.2mg Tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
How Glemevose 1mg/500mg/0.2mg Tablet works:
A single Glemevose tablet (1mg/500mg/0.2mg) contains a triple-drug formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Glemevose 1mg/500mg/0.2mg tablets is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Glemevose 1mg/500mg/0.2mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Glemevose 1mg/500mg/0.2mg tablets while breastfeeding is likely inadvisable. Available data from human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyUNSAFE
The use of Glemevose 1mg/500mg/0.2mg tablets is likely inadvisable for individuals with kidney impairment and should be omitted. A physician's consultation is advised. Furthermore, this medication is not suggested for those with severely compromised kidney function.
LiverCAUTION
Patients with liver disease should use Glemevose 1mg/500mg/0.2mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. In those with mild to moderate liver impairment, Glemevose 1mg/500mg/0.2mg tablets are typically initiated at a low dosage; however, their use is contraindicated in patients with severe liver disease.
What if you forget to take Glemevose 1mg/500mg/0.2mg Tablet :
Should you forget a Glemevose 1mg/500mg/0.2mg Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glemevose 1mg/500mg/0.2mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently